Part I of this blog post introduced the Bio.Diaspora technology, which tracks the spread of infectious diseases using international flight data and is transitioning from a grant-funded model to an earned-revenue model. As a business with inherent positive social impact, it may qualify for impact investments as well. However, it is still early days; this post explains how MaRS Innovation is helping maximize the potential of this project.
Share:
